Physician profile
Sean D Toomey
NPI 1003876343
$1,185,645.36
in general payments reported to CMS, 2019-2025
8 companies · $94K in 2025
The $94K reported for 2025 was more than what 97% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $287K · 2020: $157K · 2021: $164K · 2022: $273K · 2023: $196K · 2024: $15K · 2025: $94K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $269K · Travel and Lodging: $29K · Food and Beverage: $7,884.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $268,570.00 |
| Travel and Lodging | $28,885.84 |
| Food and Beverage | $7,883.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,184,735.71 | 2019-2025 | Mako, Insignia, Accolade |
| Davol INC. | $514.23 | 2025 | Arista |
| Becton, Dickinson and Company | $164.35 | 2024 | Arista Ah Flexitip |
| Depuy Synthes Sales INC. | $106.65 | 2019 | |
| Medacta USA, INC. | $59.00 | 2023 | Gmk Sphere |
| Tersera Therapeutics LLC | $32.23 | 2022 | |
| Radius Health, INC. | $18.39 | 2019 | |
| Ethicon US, LLC | $14.80 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sean Toomey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.